Skip to main content
Log in

High-affinity ouabain binding site and low-dose positive inotropic effect in rat myocardium

  • Letter
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

The mechanism of the positive inotropic effect of digitalis glycosides remains unclear. One theory suggests a causal relationship between the binding to and consequent inhibition of (Na++K+) ATPase (the sodium pump) by digitalis and an increased myocardial contractile force1–6. By this mechanism, the increased force of contraction would occur secondary to an elevation of intracellular sodium concentration which then causes an increased intracellular concentration of calcium via a sodium–calcium exchange mechanism4–6. Another theory proposes that the binding of digitalis to (Na++K+) ATPase causes an increase in a sarcolemmal calcium pool6–9, suggesting that the inotropic effect could be due to a causal relationship between the formation of the digitalis–(Na++K+)ATPase receptor complex and increased myocardial calcium availability and utilization, exclusive of an inhibition of the sodium pump7–9. We now report that two distinct positive inotropic sites for ouabain exist in rat ventricular strips. The higher-affinity response (ED50 = 0.5 µM) correlates with an apparent high-affinity site which can be detected by 3H-ouabain binding to intact rat ventricular myocytes. These higher-affinity sites do not correlate with concentrations (IC50) of ouabain necessary to inhibit (Na++K+)ATPase activity of sarcolemma preparations prepared from rat ventricles, suggesting that in the rat ventricle the high-affinity site for the inotropic effect of ouabain may not be related to inhibition of (Na++K+)ATPase. The low-affinity site is, however, related to inhibition of this enzyme.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Repke, K. H. R. in New Aspects of Cardiac Glycosides (ed. Wilbrandt, W.) 47–73 (Pergamon, London, 1963).

    Google Scholar 

  2. Besch, H. R. Jr, Allen, J. C., Glick, G. & Schwartz, A. J. Pharmac. exp. Ther. 171, 1–12 (1970).

    CAS  Google Scholar 

  3. Akera, T., Larsen, F. S. & Brody, T. J. Pharmac. exp. Ther. 173, 145–151 (1970).

    CAS  Google Scholar 

  4. Schwartz, A., Lindenmayer, G. E. & Allen, J. C. Pharmac. Rev. 27, 3–134 (1975).

    CAS  Google Scholar 

  5. Akera, T. & Brody, T. M. Pharmac. Rev. 29, 187–220 (1978).

    Google Scholar 

  6. Schwartz, A. & Adams, R. J. Circulation Res. 46, 1154–1160 (1980).

    Google Scholar 

  7. Gervais, A., Lane, L. K., Anner, B. M., Lindenmayer, G. E. & Schwartz, A. Circulation Res. 40, 8–14 (1977).

    Article  CAS  Google Scholar 

  8. Busse, F., Lullmann, H. & Peters, T. J. cardiovascular pharmac. 1, 687–698 (1979).

    Article  CAS  Google Scholar 

  9. Lullmann, H. & Peters, T. Prog. Pharmac. 2, 1–57 (1979).

    Google Scholar 

  10. Erdmann, E., Philipp, G. & Scholz, H. Biochem. Pharmac. 29, 3219–3229 (1980).

    Article  CAS  Google Scholar 

  11. Grupp, G., Grupp, I., Johnson, C. L., Wallick, E. T. & Schwartz, A. Biochem. biophys. Res. Commun. 88, 440–447 (1979).

    Article  CAS  Google Scholar 

  12. Wallick, E. T., Lane, L. K. & Schwartz, A. A. Rev. Physiol. 41, 397–411 (1979).

    Article  CAS  Google Scholar 

  13. Fricke, U. & Klaus, W. Br. J. Pharmac. 61, 23–428 (1977).

    Article  Google Scholar 

  14. Heller, M. & Beck, S. Biochim. biophys. Acta 514, 332–347 (1978).

    Article  CAS  Google Scholar 

  15. Wellsmith, N. V. & Lindenmayer, G. E. Circulation Res. 47, 710–720 (1980).

    Article  CAS  Google Scholar 

  16. Onji, T. & Liu, M.-S. Archs Biochem. Biophys. 207, 148–156 (1981).

    Article  CAS  Google Scholar 

  17. Sweadner, K. J. J. biol. Chem. 254, 6060–6067 (1979).

    CAS  PubMed  Google Scholar 

  18. Powell, T. & Twist, V. W. Biochem. biophys. Res. Commun. 72, 327–333 (1976).

    Article  CAS  Google Scholar 

  19. Powell, T., Terrar, D. A. & Twist, V. W. J. Physiol., Lond. 302, 131–153 (1980).

    Article  CAS  Google Scholar 

  20. Akera, T. & Chang, V.-J. K. Biochim. biophys. Acta 470, 412–423 (1977).

    Article  CAS  Google Scholar 

  21. Allen, J. C. & Schwartz, A. Pharmac. exp. Ther. 168, 42–46 (1969).

    CAS  Google Scholar 

  22. Wallick, E. T., Pitts, B. J. R., Lane, L. K. & Schwartz, A. Archs Biochem. Biophys. 202, 442–449 (1980).

    Article  CAS  Google Scholar 

  23. Sharma, V. K. & Banerjee, S. P. Molec. Pharmac. 14, 122–129 (1978).

    CAS  Google Scholar 

  24. Repke, K., Est, M. & Portius, H. J. Biochem. Pharmac. 14, 1785–1802 (1965).

    Article  CAS  Google Scholar 

  25. Akera, T., Larsen, F. S. & Brody, T. M. J. Pharmac. exp. Ther. 170, 17–26 (1969).

    CAS  Google Scholar 

  26. Godfraind, T. & Ghysel-Burton, J. Nature 265, 165–166 (1977).

    Article  ADS  CAS  Google Scholar 

  27. Ghysel-Burton, J. & Godfraind, T. Br. J. Pharmac. 66, 175–184 (1979).

    Article  CAS  Google Scholar 

  28. Godfraind, T. & Ghysel-Burton, J. Proc. natn. Acad. Sci. U.S.A. 77, 3067–3069 (1980).

    Article  ADS  CAS  Google Scholar 

  29. Noble, D. Cardiovascular Res. 14, 495–514 (1980).

    Article  CAS  Google Scholar 

  30. Grupp, G., Grupp, I., Schwartz, A., Ghysel-Burton, J. & Godfraind, T. J. Pharmac. exp. Ther. (in the press).

  31. Eisner, D. A., Lederer, W. J. & Vaughan-Jones, R. D. J. Physiol., Lond. 317, 163–187 (1981).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adams, R., Schwartz, A., Grupp, G. et al. High-affinity ouabain binding site and low-dose positive inotropic effect in rat myocardium. Nature 296, 167–169 (1982). https://doi.org/10.1038/296167a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/296167a0

  • Springer Nature Limited

This article is cited by

Navigation